(Q73372991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

N Zamberlan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Castello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Gatti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Rossini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Braga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Fracassi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Adami

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

133-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9166393%20AND%20SRC:MED&resulttype=core&format=json

Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results

3 November 2019

cites work

1 reference

12 December 2020

Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*

1 reference

12 December 2020

Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency

1 reference

12 December 2020

Reduced bone mass in reproductive-aged women with endometriosis.

1 reference

12 December 2020

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

1 reference

12 December 2020

Relative contributions of aging and estrogen deficiency to postmenopausal bone loss

1 reference

12 December 2020

Early menopausal changes in bone mass and sex steroids.

1 reference

12 December 2020

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

12 December 2020

Bone mass in hirsute women with androgen excess

1 reference

12 December 2020

Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea

1 reference

12 December 2020

The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

1 reference

12 December 2020

Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?

1 reference

12 December 2020

Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3

1 reference

12 December 2020

Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study

1 reference

12 December 2020

Increased bone turnover during gonadotropin-releasing hormone superagonist-induced ovulation inhibition.

1 reference

12 December 2020

The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis

1 reference

12 December 2020

The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change.

1 reference

12 December 2020

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

1 reference

12 December 2020

The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy

1 reference

12 December 2020

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

1 reference

12 December 2020

Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism

1 reference

12 December 2020

Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin

1 reference

12 December 2020